MEDUSA study
Research type
Research Study
Full title
Evaluation of patient experiences of migraine management and feasibility of a digital headache diary in primary care setting: a prospective cohort survey and evaluative study. MEDUSA study – Migraine: Evaluation of Diagnosis, Utilisation of Services and Applications
IRAS ID
279980
Contact name
Stacey Fisher
Contact email
Sponsor organisation
North Cumbria Integrated Care NHS Foundation Trust
Clinicaltrials.gov Identifier
Clinicaltrials.gov Identifier
279980, 279980
Duration of Study in the UK
0 years, 8 months, 1 days
Research summary
Migraine is a very common condition characterised by frequent severe headaches that are very debilitating. Although the frequency and severity does reduce as patients age, particularly above the age of 70, in younger and working age people this condition has a significant impact on people’s lives. Patients with migraine are typically diagnosed and managed in primary care, but can also be treated by neurologists. Recently, NHS England has published guidance for clinical staff to optimise patient management: reduce admissions to hospital for migraine and improve the setting in which patients are seen. One recommendation is the increased use of headache diaries by patients. These may help patients and doctors to improve migraine diagnosis and its treatment, for example by identifying if there are triggers for getting a migraine attack. With technological advancements, there are now computer/phone applications (Apps) that can be used instead of a paper diary. The Curelator N1 Headache App is one of such migraine specific Apps. In this study, we aim to evaluate if primary care migraine patients are open to using a digital headache diary App, and how compliant users of the App will be. We also aim to assess patient feedback on the use of the Curelator App, and if its use aids them in the management of their migraine.
REC name
Yorkshire & The Humber - South Yorkshire Research Ethics Committee
REC reference
20/YH/0223
Date of REC Opinion
9 Sep 2020
REC opinion
Further Information Favourable Opinion